RGEN REPLIGEN CORP
Nasdaq · SEC CIK 730272 · EDGAR
- Bought, last 12 months
- $0 0 purchases by 0 insiders
- Sold, last 12 months
- $11.77M 11 sales by 5 insiders
- Filings on record
- 208 since 2021-07-15, latest 2026-09-22 16:07
BoughtSold
Most active insiders, 12 months
| Insider | Title | Bought | Sold |
|---|---|---|---|
| Hunt Anthony | Dir | — | $7.01M |
| Loeillot Olivier | CEO, Dir | — | $4.19M |
| Bylund James | COO | — | $331.3K |
| Garland Jason K | CFO | — | $185.8K |
| DAWES KAREN A | Dir | — | $44.3K |
| Douglass Brian Robb | Chief PRODUCT Off | — | — |
| Pax Margaret | Dir | — | — |
| Hughes Violetta | CAO | — | — |
| Mhatre Rohin | Dir | — | — |
| Konstantinov Konstantin | Dir | — | — |
Transactions 266
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| MT | 2024-05-22 | 2024-05-21 | RGEN | Hunt Anthony | CEO | S - Sale | $168.26 | -20.1K | 168.1K | -11% | -$3.38M |
| D | 2024-05-20 | 2024-05-16 | RGEN | EGLINTON MANNER CARRIE | Dir | A - Grant | $0.00 | +701 | 3,493 | +25% | $0 |
| D | 2024-05-20 | 2024-05-16 | RGEN | BARTHELEMY NICOLAS | Dir | A - Grant | $0.00 | +701 | 3,468 | +25% | $0 |
| D | 2024-05-20 | 2024-05-16 | RGEN | Pax Margaret | Dir | A - Grant | $0.00 | +701 | 793 | +762% | $0 |
| D | 2024-05-20 | 2024-05-16 | RGEN | Mhatre Rohin | Dir | A - Grant | $0.00 | +701 | 3,046 | +30% | $0 |
| D | 2024-05-20 | 2024-05-16 | RGEN | DAWES KAREN A | Dir | A - Grant | $0.00 | +803 | 88.2K | +0.9% | $0 |
| D | 2024-05-20 | 2024-05-16 | RGEN | Konstantinov Konstantin | Dir | A - Grant | $0.00 | +701 | 1,921 | +57% | $0 |
| D | 2024-05-20 | 2024-05-16 | RGEN | Madaus Martin D | Dir | A - Grant | $0.00 | +701 | 2,998 | +31% | $0 |
| D | 2024-05-20 | 2024-05-16 | RGEN | MUIR GLENN P | Dir | A - Grant | $0.00 | +701 | 8,283 | +9% | $0 |
| 2024-05-15 | 2024-05-14 | RGEN | KURIYEL RALF | Senior VP, R, D | F - Tax | $163.34 | -534 | 23.7K | -2% | -$87.2K | |
| 2024-05-15 | 2024-05-14 | RGEN | Gebski Christine | See Remarks | F - Tax | $163.34 | -334 | 27.4K | -1% | -$54.6K | |
| 2024-04-04 | 2024-04-02 | RGEN | Bylund James | COO | F - Tax | $182.95 | -444 | 20.6K | -2% | -$81.2K | |
| 2024-03-20 | 2024-03-18 | RGEN | Hunt Anthony | CEO | G - Gift | $0.00 | -2,000 | 183.2K | -1% | $0 | |
| D | 2024-03-19 | 2024-03-18 | RGEN | Pax Margaret | Dir | A - Grant | $0.00 | +92 | 92 | New | $0 |
| D | 2024-03-12 | 2024-03-11 | RGEN | KURIYEL RALF | Senior VP, R, D | S - Sale+OE | $193.73 | -3,517 | 24.3K | -13% | -$681.3K |
| D | 2024-03-12 | 2024-03-11 | RGEN | KURIYEL RALF | Senior VP, R, D | M - OptEx | $86.10 | +1,271 | 27.8K | +5% | +$109.4K |
| DMT | 2024-03-11 | 2024-03-08 | RGEN | Hunt Anthony | CEO | S - Sale+OE | $197.44 | -16.7K | 192.4K | -8% | -$3.30M |
| DT | 2024-03-11 | 2024-03-08 | RGEN | Hunt Anthony | CEO | M - OptEx | $16.55 | +1 | 202.0K | +0.0% | +$16.55 |
| 2024-03-07 | 2024-03-07 | RGEN | Gebski Christine | See Remarks | F - Tax | $195.72 | -386 | 27.8K | -1% | -$75.5K | |
| 2024-03-07 | 2024-03-07 | RGEN | Hunt Anthony | CEO | F - Tax | $195.72 | -2,867 | 202.0K | -1% | -$561.1K | |
| 2024-03-07 | 2024-03-07 | RGEN | KURIYEL RALF | Senior VP, R, D | F - Tax | $195.72 | -386 | 26.5K | -1% | -$75.5K | |
| 2024-03-07 | 2024-03-07 | RGEN | Bylund James | COO | F - Tax | $195.72 | -1,206 | 21.0K | -5% | -$236.0K | |
| 2024-03-06 | 2024-03-04 | RGEN | Gebski Christine | See Remarks | F - Tax | $193.99 | -131 | 28.1K | -0.5% | -$25.4K | |
| M | 2024-03-06 | 2024-03-04+ | RGEN | Bylund James | COO | F - Tax | $194.14 | -219 | 22.3K | -1.0% | -$42.5K |
| M | 2024-03-06 | 2024-03-04+ | RGEN | Hunt Anthony | CEO | F - Tax | $195.32 | -8,386 | 212.1K | -4% | -$1.64M |
| 2024-03-06 | 2024-03-04 | RGEN | KURIYEL RALF | Senior VP, R, D | F - Tax | $193.99 | -135 | 26.9K | -0.5% | -$26.2K | |
| 2024-03-05 | 2024-03-01 | RGEN | Bylund James | COO | A - Grant | $0.00 | +50 | 22.5K | +0.2% | $0 | |
| 2024-03-04 | 2024-03-01 | RGEN | Hunt Anthony | CEO | F - Tax | $191.79 | -3,322 | 213.2K | -2% | -$637.1K | |
| 2024-03-04 | 2024-02-29 | RGEN | Hunt Anthony | CEO | A - Grant | $0.00 | +2,504 | 216.5K | +1% | $0 | |
| M | 2024-03-04 | 2024-03-01+ | RGEN | Gebski Christine | See Remarks | F - Tax | $192.26 | -908 | 28.7K | -3% | -$174.6K |
| 2024-03-04 | 2024-02-29 | RGEN | Gebski Christine | See Remarks | A - Grant | $0.00 | +391 | 29.2K | +1% | $0 | |
| 2024-03-04 | 2024-03-01 | RGEN | Bylund James | COO | F - Tax | $191.79 | -820 | 22.4K | -4% | -$157.3K | |
| 2024-03-04 | 2024-02-29 | RGEN | Bylund James | COO | A - Grant | $0.00 | +404 | 23.2K | +2% | $0 | |
| 2024-03-04 | 2024-03-01 | RGEN | KURIYEL RALF | Senior VP, R, D | F - Tax | $191.79 | -453 | 27.0K | -2% | -$86.9K | |
| 2024-03-04 | 2024-02-29 | RGEN | KURIYEL RALF | Senior VP, R, D | A - Grant | $0.00 | +404 | 27.5K | +1% | $0 | |
| D | 2024-02-29 | 2024-02-27 | RGEN | Garland Jason K | CFO | A - Grant | $0.00 | +2,540 | 8,043 | +46% | $0 |
| D | 2024-02-29 | 2024-02-27 | RGEN | Loeillot Olivier | Pres, CCO | A - Grant | $0.00 | +2,880 | 15.8K | +22% | $0 |
| D | 2024-02-29 | 2024-02-27 | RGEN | Hunt Anthony | CEO | A - Grant | $0.00 | +19.7K | 214.0K | +10% | $0 |
| D | 2024-02-29 | 2024-02-27 | RGEN | Bylund James | COO | A - Grant | $0.00 | +8,691 | 22.8K | +61% | $0 |
| D | 2024-02-29 | 2024-02-27 | RGEN | KURIYEL RALF | Senior VP, R, D | A - Grant | $0.00 | +3,520 | 27.1K | +15% | $0 |
| D | 2024-02-28 | 2024-02-27 | RGEN | DAWES KAREN A | Dir | S - Sale+OE | $193.35 | -1,000 | 87.4K | -1% | -$193.3K |
| D | 2024-02-28 | 2024-02-27 | RGEN | DAWES KAREN A | Dir | M - OptEx | $42.07 | +4,626 | 88.4K | +6% | +$194.6K |
| D | 2024-02-26 | 2024-02-23 | RGEN | Bylund James | COO | S - Sale+OE | $198.08 | -4,373 | 14.1K | -24% | -$866.2K |
| D | 2024-02-26 | 2024-02-23 | RGEN | Bylund James | COO | M - OptEx | $94.33 | +940 | 18.5K | +5% | +$88.7K |
| 2023-11-16 | 2023-11-14 | RGEN | Hunt Anthony | CEO | G - Gift | $0.00 | -1,000 | 194.3K | -0.5% | $0 | |
| 2023-11-13 | 2023-11-10 | RGEN | Gebski Christine | See Remarks | S - Sale | $147.13 | -3,788 | 28.8K | -12% | -$557.3K | |
| D | 2023-10-03 | 2023-10-02 | RGEN | Loeillot Olivier | Pres, CCO | A - Grant | $0.00 | +12.9K | 12.9K | New | $0 |
| D | 2023-09-27 | 2023-09-25 | RGEN | Garland Jason K | CFO | A - Grant | $0.00 | +5,503 | 5,503 | New | $0 |
| D | 2023-08-30 | 2023-08-29 | RGEN | DAWES KAREN A | Dir | S - Sale+OE | $171.38 | -850 | 83.7K | -1% | -$145.7K |
| D | 2023-08-30 | 2023-08-29 | RGEN | DAWES KAREN A | Dir | M - OptEx | $18.12 | +7,392 | 84.6K | +10% | +$133.9K |
| D | 2023-05-22 | 2023-05-18 | RGEN | MUIR GLENN P | Dir | A - Grant | $0.00 | +686 | 7,582 | +10% | $0 |
| D | 2023-05-22 | 2023-05-18 | RGEN | BARTHELEMY NICOLAS | Dir | A - Grant | $0.00 | +686 | 2,767 | +33% | $0 |
| D | 2023-05-22 | 2023-05-18 | RGEN | EGLINTON MANNER CARRIE | Dir | A - Grant | $0.00 | +686 | 2,167 | +46% | $0 |
| D | 2023-05-22 | 2023-05-18 | RGEN | Mhatre Rohin | Dir | A - Grant | $0.00 | +686 | 2,345 | +41% | $0 |
| D | 2023-05-22 | 2023-05-18 | RGEN | Madaus Martin D | Dir | A - Grant | $0.00 | +686 | 2,297 | +43% | $0 |
| D | 2023-05-22 | 2023-05-18 | RGEN | DAWES KAREN A | Dir | A - Grant | $0.00 | +798 | 77.2K | +1% | $0 |
| D | 2023-05-22 | 2023-05-18 | RGEN | Konstantinov Konstantin | Dir | A - Grant | $0.00 | +686 | 1,220 | +128% | $0 |
| 2023-05-16 | 2023-05-16 | RGEN | Snodgres Jon | CFO | F - Tax | $154.03 | -710 | 37.4K | -2% | -$109.4K | |
| 2023-05-16 | 2023-05-16 | RGEN | KURIYEL RALF | Senior VP, R, D | F - Tax | $154.03 | -710 | 23.6K | -3% | -$109.4K | |
| 2023-05-16 | 2023-05-16 | RGEN | Gebski Christine | See Remarks | F - Tax | $154.03 | -334 | 32.6K | -1% | -$51.4K | |
| M | 2023-05-08 | 2023-05-04+ | RGEN | Madaus Martin D | Dir | P - Purchase | $158.84 | +1,500 | 611 | New | +$238.3K |
| I | 2023-05-08 | 2023-03-24 | RGEN | Madaus Martin D | Dir | L - Small Acq | $186.22 | +11 | 11 | New | +$2,048 |
| 2023-04-04 | 2023-04-04 | RGEN | Bylund James | COO | F - Tax | $163.45 | -334 | 17.6K | -2% | -$54.6K | |
| DM | 2023-03-06 | 2023-03-02+ | RGEN | KURIYEL RALF | Senior VP, R, D | A - Grant | $0.00 | +7,059 | 25.5K | +38% | $0 |
| D | 2023-03-06 | 2023-03-03 | RGEN | KURIYEL RALF | Senior VP, R, D | F - Tax | $188.00 | -1,247 | 24.3K | -5% | -$234.4K |
| DM | 2023-03-06 | 2023-03-02+ | RGEN | Bylund James | COO | A - Grant | $0.00 | +8,973 | 18.1K | +98% | $0 |
| D | 2023-03-06 | 2023-03-03 | RGEN | Bylund James | COO | F - Tax | $188.00 | -210 | 17.9K | -1% | -$39.5K |
| DM | 2023-03-06 | 2023-03-02+ | RGEN | Snodgres Jon | CFO | A - Grant | $0.00 | +13.6K | 33.0K | +71% | $0 |
| D | 2023-03-06 | 2023-03-03 | RGEN | Snodgres Jon | CFO | F - Tax | $188.00 | -3,674 | 38.1K | -9% | -$690.7K |
| DM | 2023-03-06 | 2023-03-02+ | RGEN | Gebski Christine | See Remarks | A - Grant | $0.00 | +3,842 | 32.7K | +13% | $0 |
| D | 2023-03-06 | 2023-03-03 | RGEN | Gebski Christine | See Remarks | F - Tax | $188.00 | -126 | 32.9K | -0.4% | -$23.7K |
| DM | 2023-03-06 | 2023-03-02+ | RGEN | Hunt Anthony | CEO, Dir | A - Grant | $0.00 | +38.0K | 203.6K | +23% | $0 |
| D | 2023-03-06 | 2023-03-03 | RGEN | Hunt Anthony | CEO, Dir | F - Tax | $188.00 | -8,244 | 195.3K | -4% | -$1.55M |
| M | 2023-03-02 | 2023-02-28+ | RGEN | Gebski Christine | See Remarks | F - Tax | $173.91 | -1,090 | 29.8K | -4% | -$189.6K |
| M | 2023-03-02 | 2023-02-28+ | RGEN | Hunt Anthony | CEO, Dir | F - Tax | $175.47 | -9,418 | 165.6K | -5% | -$1.65M |
| 2023-03-01 | 2023-02-28 | RGEN | Snodgres Jon | CFO | F - Tax | $173.28 | -521 | 28.1K | -2% | -$90.3K | |
| 2023-03-01 | 2023-02-28 | RGEN | KURIYEL RALF | Senior VP, R, D | F - Tax | $173.28 | -358 | 18.5K | -2% | -$62.0K | |
| 2023-02-28 | 2023-02-28 | RGEN | Bylund James | COO | F - Tax | $173.44 | -594 | 9,139 | -6% | -$103.0K | |
| 2023-02-28 | 2023-02-28 | RGEN | KURIYEL RALF | Senior VP, R, D | F - Tax | $173.44 | -458 | 18.8K | -2% | -$79.4K | |
| 2023-02-28 | 2023-02-28 | RGEN | Gebski Christine | See Remarks | F - Tax | $173.44 | -452 | 30.3K | -1% | -$78.4K | |
| 2023-02-28 | 2023-02-28 | RGEN | Snodgres Jon | CFO | F - Tax | $173.44 | -682 | 28.6K | -2% | -$118.3K | |
| 2023-02-28 | 2023-02-28 | RGEN | Hunt Anthony | CEO, Dir | F - Tax | $173.44 | -3,273 | 175.0K | -2% | -$567.7K | |
| 2023-02-17 | 2023-02-16 | RGEN | Snodgres Jon | CFO | S - Sale | $200.00 | -5,647 | 29.3K | -16% | -$1.13M | |
| D | 2023-02-08 | 2023-02-06 | RGEN | Madaus Martin D | Dir | A - Grant | $0.00 | +111 | 111 | New | $0 |
| 2022-12-15 | 2022-03-16 | RGEN | EGLINTON MANNER CARRIE | Dir | P - Purchase | $175.02 | +625 | 2,106 | +42% | +$109.4K | |
| D | 2022-11-14 | 2022-11-11 | RGEN | Hunt Anthony | CEO, Dir | M - OptEx | $33.87 | +25.0K | 203.3K | +14% | +$846.7K |
| D | 2022-11-14 | 2022-11-11 | RGEN | Hunt Anthony | CEO, Dir | S - Sale+OE | $200.00 | -25.0K | 178.3K | -12% | -$5.00M |
| D | 2022-10-11 | 2022-10-07 | RGEN | Snodgres Jon | CFO | M - OptEx | $59.52 | +466 | 35.0K | +1% | +$27.7K |
| DM | 2022-09-09 | 2022-09-08 | RGEN | Hunt Anthony | CEO, Dir | S - Sale+OE | $224.73 | -26.4K | 203.8K | -11% | -$5.93M |
| D | 2022-09-09 | 2022-09-08 | RGEN | Hunt Anthony | CEO, Dir | M - OptEx | $33.87 | +10.0K | 204.7K | +5% | +$338.7K |
| 2022-09-09 | 2022-09-09 | RGEN | DAWES KAREN A | Dir | S - Sale | $227.17 | -775 | 76.4K | -1% | -$176.1K | |
| DM | 2022-08-17 | 2022-08-16 | RGEN | Snodgres Jon | CFO | S - Sale+OE | $252.86 | -6,698 | 36.9K | -15% | -$1.69M |
| DM | 2022-08-17 | 2022-08-16 | RGEN | Snodgres Jon | CFO | M - OptEx | $117.37 | +4,017 | 41.2K | +11% | +$471.5K |
| DM | 2022-08-12 | 2022-08-11 | RGEN | KURIYEL RALF | Senior VP, R, D | M - OptEx | $50.58 | +4,000 | 22.1K | +22% | +$202.3K |
| DM | 2022-08-12 | 2022-08-11 | RGEN | KURIYEL RALF | Senior VP, R, D | S - Sale+OE | $254.32 | -4,840 | 23.3K | -17% | -$1.23M |
| 2022-08-05 | 2022-08-04 | RGEN | Gebski Christine | See Remarks | S - Sale | $243.01 | -3,357 | 30.7K | -10% | -$815.8K | |
| D | 2022-08-04 | 2022-08-03 | RGEN | Bylund James | COO | S - Sale+OE | $240.40 | -2,000 | 9,733 | -17% | -$480.8K |
| D | 2022-08-04 | 2022-08-03 | RGEN | Bylund James | COO | M - OptEx | $94.33 | +2,000 | 11.7K | +21% | +$188.7K |
| 2022-08-02 | 2022-08-01 | RGEN | Snodgres Jon | CFO | S - Sale | $220.00 | -2,000 | 37.2K | -5% | -$440.0K | |
| DM | 2022-07-22 | 2022-07-21 | RGEN | Hunt Anthony | CEO, Dir | M - OptEx | $32.76 | +20.2K | 219.5K | +10% | +$660.3K |
Purchase Sale Sale after option exercise All abbreviations